XT
CNTA

XTX Topco’s Centessa Pharmaceuticals CNTA Stock Holding History

XTX Topco’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-79,077
Closed -$1.98M – 3902
2025
Q4 		$1.98M Buy
+79,077
New +$2M 0.05% 571
2025
Q3 		– Sell
-35,898
Closed -$472K – 2671
2025
Q2 		$472K Sell
35,898
-5,159
-13% -$65.4K 0.02% 1139
2025
Q1 		$590K Buy
41,057
+18,377
+81% +$301K 0.03% 906
2024
Q4 		$380K Buy
22,680
+12,506
+123% +$207K 0.03% 1012
2024
Q3 		$163K Sell
10,174
-6,211
-38% -$76.1K 0.01% 1501
2024
Q2 		$148K Buy
+16,385
New +$155K 0.01% 1327

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

XTX Topco's CNTA Position: Q1 2026 in Review

XTX Topco sold out of Centessa Pharmaceuticals (CNTA) in Q1 2026, closing a stake of 79,077 shares — an estimated $1.98M sold.

XTX Topco first reported a position in CNTA in Q2 2024 and held it in 6 quarters. The position peaked at $1.98M in Q4 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • XTX Topco reported no remaining Centessa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 79,077 Centessa Pharmaceuticals shares in Q1 2026, an estimated $1.98M.
  • XTX Topco first reported a position in Centessa Pharmaceuticals in Q2 2024 and held it in 6 quarters.
  • XTX Topco's Centessa Pharmaceuticals position peaked at $1.98M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.